Giant obscurins regulate the PI3K cascade in breast epithelial cells via direct binding to the PI3K/p85 regulatory subunit

Authors:

Abstract
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Marey Shriver1, #, Saravanakumar Marimuthu1, #, Colin Paul2, 3, 4, *, Janelle Geist1, *, Tessa Seale1, Konstantinos Konstantopoulos2, 3, 4, Aikaterini Kontrogianni-Konstantopoulos1, 5 1University of Maryland School of Medicine, Department of Biochemistry and Molecular Biology, Baltimore, MD 21201 2Johns Hopkins University, Department of Chemical and Biomolecular Engineering, Baltimore, MD 21218 3Johns Hopkins Institute for NanoBioTechnology, The Johns Hopkins University, Baltimore, MD 21218 4Johns Hopkins Physical Sciences-Oncology Center, The Johns Hopkins University, Baltimore, MD 21218 5University of Maryland School of Medicine, Marlene and Stewart Greenebaum National Cancer Institute Cancer Center, Baltimore, MD 21201 #These authors contributed equally to this work *These authors contributed equally to this work Correspondence to: Aikaterini Kontrogianni-Konstantopoulos, email: akontrogianni@som.umaryland.edu Keywords: obscurin, PI3K, PI3K inhibitors, Akt, breast cancer Received: March 02, 2016 Accepted: May 29, 2016 Published: June 13, 2016

This publication has 57 references indexed in Scilit: